IntegraMed America, Incorporation.  

(Public, NASDAQ:INMD)   Watch this stock  
Find more results for INMD
Sep 20 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 6.70 - 14.13
Open     -
Vol / Avg. 0.00/45,922.00
Mkt cap 168.53M
P/E 33.01
Div/yield     -
EPS 0.43
Shares     -
Beta 0.82
Inst. own     -

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 0.62% 1.68%
Operating margin 1.40% 2.76%
EBITD margin - 6.59%
Return on average assets 1.17% 3.00%
Return on average equity 2.08% 5.32%
Employees 1,368 -
CDP Score - -


PURCHASE, NY 10577-2100
United States - Map
+1-914-2538000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


IntegraMed America, Inc., is a United States-based company, which provides healthcare services. The Company manages clinical facilities which provide ART services to infertile couples. The ART program incorporates medical, psychological and financial counseling with ART (assisted reproductive technology) therapeutic procedures, such as in vitro fertilization (IVF), gamate intrafallopian transfer (GIFT) and microinsemination. It offers a suite of management support and infrastructure, which include: clinical and business information systems, sales and marketing, facilities and operations management, finance and accounting, human resources, legal and risk management and quality assurance.